107 filings
Page 3 of 6
6-K
vt9nrer22azyhf8
17 Aug 22
Current report (foreign)
4:18pm
6-K
rf81beebr2aycpqxbaj
20 Jul 22
First Half Trading Update
7:46am
6-K
q2keoi
18 May 22
Result of Annual General Meeting
12:03pm
20-F/A
57ybi63
8 Apr 22
Annual report (foreign) (amended)
7:02am
S-8
xe2t1hv uup
29 Mar 22
Registration of securities for employees
4:34pm
F-3ASR
f3a2rn tztj6y
29 Mar 22
Automatic shelf registration (foreign)
4:30pm
6-K
cfc4o5q2
17 Mar 22
Current report (foreign)
11:03am
6-K
jd8ze7ym jy
14 Mar 22
Results for the 12- and 18-month periods ended 31 December 2021
8:15am
6-K
27d 3nxho
28 Feb 22
Current report (foreign)
9:25am
6-K
2x48 dww0ar
27 Jan 22
Current report (foreign)
7:00am
6-K
yq2948pt2
3 Dec 21
Update on 2021 General Meeting Resolution Vote
2:22pm
6-K
l3ir58bye
12 Nov 21
Current report (foreign)
6:32am
6-K
oidvttof
27 Oct 21
Abcam Completes Acquisition of BioVision
6:15am
6-K
laaat kfuqznau9qvp
13 Sep 21
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
7:01am
6-K
ff56j30m0 k11
1 Sep 21
Filing of Transition Report on Form 20-F and Notice of Results
7:29am
20-F
n2zrop8ddjrxx391i
1 Sep 21
Annual report (foreign)
7:26am
6-K
mjaablogpjkwyqc91kj
13 Aug 21
Appointment of Non-Executive Director
6:10am
6-K
mw1w31
2 Aug 21
Abcam to Acquire BioVision for $340 million
6:12am
S-8
xscjz9isq
14 Jul 21
Registration of securities for employees
4:02pm